SpringWorks Therapeutics, a healthcare company of Merck KGaA, Darmstadt, Germany, is a commercial-stage biopharmaceutical company dedicated to improving the lives of patients with rare tumors. We developed and are commercializing the first and only FDA and EC approved medicine for adults with desmoid tumors and the first and only FDA and EC approved medicine for both adults and children with neurofibromatosis type 1 associated plexiform neurofibromas (NF1-PN). At SpringWorks, we are committed to finding answers people with rare tumors need. We thrive in an atmosphere of passion and tenacity, fueled by the excitement of the possibilities science may unlock and driven to work with urgency because of the importance of our work. We value authenticity because diverse backgrounds, cultures, styles and abilities can only help us find the answers that people with rare tumors are looking for . The Associate Director, Payer & Access Marketing- US Rare Tumors (OGSIVEO) will help shape and execute the OGSIVEO® value proposition across US market access channels. This role will lead the development of customer-facing value narratives, access-focused strategy, and tactical execution for key market access audiences, including payers, population-based decision-makers, pharmacists, GPOs, and external thought leaders. The role requires strong cross-functional leadership across Commercial, including marketing, sales, market research, market access, and patient services, as well as close partnership with finance, medical, legal, and regulatory.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level